Nautilus Biotechnology (NAUT) Cash & Equivalents Growth (1y) (2021 - 2026)
Nautilus Biotechnology (NAUT) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 23.81% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 71.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Nautilus Biotechnology | 212.11 Mn | 116.24 Mn | - | -56.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.00% |
| Dec 31, 2025 | -55.19% |
| Sep 30, 2025 | 441.51% |
| Jun 30, 2025 | 38.46% |
| Mar 31, 2025 | 29.18% |
| Dec 31, 2024 | 42.53% |
| Sep 30, 2024 | -94.05% |
| Jun 30, 2024 | -65.50% |
| Mar 31, 2024 | -70.93% |
| Dec 31, 2023 | -83.06% |
| Sep 30, 2023 | -60.78% |
| Jun 30, 2023 | -65.71% |
| Mar 31, 2023 | -53.08% |
| Dec 31, 2022 | -38.30% |
| Sep 30, 2022 | -0.69% |
| Jun 30, 2022 | -27.06% |
| Mar 31, 2022 | 27,556.78% |
| Dec 31, 2021 | 407.06% |
| Sep 30, 2021 | 17,763.78% |